
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8948 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Paraquat-d8 Dichloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Labelled Paraquat Dichloride, a commonly used heribicide. Paraquat Dichloride is a fast-acting and non-selective viologen derivative that kills green plant tissue on contact. Studies suggest that there might be a possible link between Paraquat Dichloride and the development of Parkinson’s disease.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Heylings, J.R. et al.: Toxicology, 241, 1 (2007); Wibawa, W. et al.: Int. J. Agric. Biol., 11, 145 (2009); Franco, R. et al.: Chem.-Biol. Inter., 188, 289 (2010);<br></p>Formula:C122H8H6N2·2ClColor and Shape:ColourlessMolecular weight:265.21(6R)-5,6,7,8-Tetrahydrobiopterin Dihydrochloride
CAS:<p>Stability Hygroscopic<br>Applications Tetrahydrobiopterin is a naturally occurring essential cofactor of the three aromatic amino acid hydroxylase enzymes, used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin, melatonin, dopamine, norepinephrine , epinephrine, and is a cofactor for the production of nitric oxide by the nitric oxide synthases. Chemically, its structure is that of a reduced pteridine derivative.<br>References Levy, Harvey L., et al.: Lancet, 370, 504 (2007); Isojima, Yasushi., et al.: Proc Natl Acad Sci USA .,106, 15744 (2009); Burton, B. K., et al.: J. Inherit. Metab. Dis., 30, 700 (2007)<br></p>Formula:C9H15N5O3·2(HCl)Color and Shape:White To Off-WhiteMolecular weight:241.25 + 2(36.46)1-phenyl-5-[(pyrimidin-2-ylsulfanyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid
CAS:Purity:95.0%Molecular weight:313.33999633789062,4,5,6-Tetraaminopyrimidine Sulfate
CAS:Controlled Product<p>Applications Intermediate in the production of Methotrexate<br>References Chiosis, G., et al.: Bioorg. Med. Chem., 10, 3555 (2002), Palanki, M., et al.: J. Med. Chem., 50, 4279 (2007), Zav'yalov, S., et al.: Pharm. Chem. J., 42, 51 (2008),<br></p>Formula:C4H8N6·H2O4SColor and Shape:NeatMolecular weight:238.223-Nitropyridine
CAS:Controlled Product<p>Applications Used in the novel synthesis of biologically active nitro heterocyclic compounds.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Pawar, N., et al.: Eur. J. Pharm. Sci., 21, 115 (2004), Badgujar, D., et al.: J. Sci. Ind. Res., 66, 250 (2007),<br></p>Formula:C5H4N2O2Color and Shape:NeatMolecular weight:124.10Orotic Acid-15N2 Monohydrate
CAS:<p>Applications Orotic Acid-15N2 Monohydrate is a labelled analogue of Orotic Acid Monohydrate (O691500(P)), which is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment.<br>References Furukawa, S.: PCT Int. Appl. (2009), WO 2009069291 A1<br></p>Formula:C5H415N2O4·H2OColor and Shape:NeatMolecular weight:177.09L-Monapterin
CAS:Controlled Product<p>Applications L-Monapterin is the major pterin compound extracted from Escherichia coli (E.coli) and is used in its detection and identification.<br>References Sugimoto, T. et al.: Hetero., 54, 283 (2001); Ikawa, M. et al.: Phytochem., 38, 1229 (1995);<br></p>Formula:C9H11N5O4Color and Shape:Light OrangeMolecular weight:253.215-(1-Biphenyl-4-yl-1H-tetrazol-5-yl)-4-methyl-pyrimidin-2-ylamine
CAS:Color and Shape:SolidMolecular weight:329.36700439453125Methotrexate a-Methyl Ester (>90%)
CAS:Controlled Product<p>Impurity Methotrexate EP Impurity I<br>Applications Methotrexate α-methyl ester is an impurity of Methotrexate (M260675), a folic acid antagonist. Used as a antineoplastic and antirheumatic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958), Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985),<br></p>Formula:C21H24N8O5Purity:>90%Color and Shape:NeatMolecular weight:468.47Methotrexate-d3
CAS:Controlled Product<p>Applications Labelled Methotrexate (M260675). A Folic acid antagonist. Used as a antineoplastic and antirheumatic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958), Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985),<br></p>Formula:C20H19D3N8O5Color and Shape:NeatMolecular weight:457.461,7-Dimethyluric Acid
CAS:Controlled Product<p>Applications A metabolite of Caffeine.<br>References Kalow, W., et al.: Clin. Pharmacol. Ther., 53, 503 (1993), Sharma, S., et al.: Cancer Res., 54, 5848 (1994), Sugawara, M., et al.: J. Biol. Chem., 275, 16473 (2000), Takeda, M., et al.: J. Pharmacol. Exp. Ther., 302, 666 (2002),<br></p>Formula:C7H8N4O3Color and Shape:NeatMolecular weight:196.164-[2’-(7’’-Deazaguanine)ethyl]benzoic Acid N-Hydroxysuccinimide Ester
CAS:Controlled Product<p>Applications Intermediate in the preparation of Pemetrexed.<br></p>Formula:C19H17N5O5Color and Shape:WhiteMolecular weight:395.373-Nitro-L-tyrosine-d3
CAS:Controlled Product<p>Applications A labelled marker for peroxynitrite. Oxidant and cytotoxic agent.<br>References Sekiguchi, M., et al.: Brain Res., 978, 228 (2003), van den Tweel, E., et al.: J. Neurobiol., 167, 64 (2005), Shirakura, T., et al.: Biol. Pharm. Bull., 28, 1658 (2005),<br></p>Formula:C9D3H7N2O5Color and Shape:NeatMolecular weight:229.2Methotrexate Heptaglutamate Trifluoroacetate
CAS:Controlled ProductFormula:C50H64N14O23xC2HF3O2Color and Shape:NeatMolecular weight:1229.126-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole
CAS:Purity:97%Molecular weight:516.719970703125Methotrexate-d3 Triglutamate Trifluoroacetate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Methotrexate-d3 Triglutamate is the isotope labelled analog of Methotrexate Triglutamate (M260725); a metabolite of Methotrexate (M260675) which is a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C30H33D3N10O11(C2HF3O2)xColor and Shape:NeatMolecular weight:715.694-Chloro Kynurenine-13C2,15N
CAS:Controlled Product<p>Applications 7-Cl-kynurenic acid (7-Cl-KYNA) is a potent, selective antagonist of the NMDA/glycine receptor but penetrates poorly through the blood-brain barrier. Its prodrug, L-4-Cl-kynurenine (4-Cl-KYN), readily enters the brain from the circulation and provides antiexcitotoxic neuroprotection after systemic application.<br>References Leeson, P., et al.: J. Med. Chem., 37, 4053 (1994), Hilmas, C., et al.: J. Neurosci., 2001, 21, 7463 (2001), Palmer, G., et al.: Curr. Drug Targets, 2, 241 (2001), Wu, H., et al.: Exp. Neurol., 177, 222 (2002),<br></p>Formula:C813C2H11ClN15NO3Color and Shape:NeatMolecular weight:245.64Allopurinol
CAS:<p>Applications Allopurinol is a xanthine oxidase inhibitor; decreases uric acid production. Used in treatment of hyperuricemia and chronic gout. Antiurolithic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Benezra, S.A., et al.: Anal. Profiles Drug Subs., 7, 1, (1978); Dalbeth, N., et al.: Rheumatology, 44, 1090 (2005); Dinarello, C., et al.: J. Exp. Med., 201, 1355 (2005);<br></p>Formula:C5H4N4OColor and Shape:Off-WhiteMolecular weight:136.116-Methylmercaptopurine-d3
CAS:Controlled Product<p>Applications Metabolite of 6-Mercaptopurine, an immunosuppressive drug used to treat leukemia.<br>References Chou, C., et al.: Biochem. Pharmacol., 75, 1601 (2008), Conejo-Garcia, A., et al.: Eur. J. Med. Chem., 43, 1742 (2008), Hawwa, A., et al.: Brit. J. Clin. Pharmacol., 66, 826 (2008), Askanase, A., et al.: J. Rheumatol., 36, 89 (2009),<br></p>Formula:C62H3H3N4SColor and Shape:NeatMolecular weight:169.22N-Hydroxymethyl Sumatriptan
CAS:Controlled Product<p>Applications Hydroxymethyl Sumatriptan is an analog of Sumatriptan (S810000), a serotonin 5HT1-receptor agonist.<br>References Humphrey, P.P.A., et al.: Brit. J. Pharmacol., 94, 1123 (1988), Doenicke, A., et al.: Lancet 1, 1309 (1988),<br></p>Formula:C15H23N3O3SColor and Shape:NeatMolecular weight:325.43N-(2-Hydroxy-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide
CAS:Purity:95+%Molecular weight:469.559997558593756-Hydroxy Ondansetron
CAS:<p>Applications A metabolite of Ondansetron.<br>References Colthup, P., et al.: J. Pharm. Sci., 80, 868 (1991), Miyauchi, S., et al.: Pharm. Res.,10, 434 (1993), Ekins, S., et al.: Drug Metab. Dispos., 23, 1274 (1995), Worboys, P., et al.: Xenobiotica, 26, 897 (1996),<br></p>Formula:C18H19N3O2Color and Shape:Off-White To Light BrownMolecular weight:309.3624-(3,3-Dipropyl-ureido)benzenesulfonyl chloride
CAS:Formula:C13H19ClN2O3SPurity:98%Color and Shape:SolidMolecular weight:318.821-(3-(BENZO[D]THIAZOL-2-YL)-4-HYDROXYPHENYL)-3-PHENYLUREA
CAS:Purity:95.0%Molecular weight:361.42001342773444-(4-Oxobutyl)benzoic Acid Methyl Ester
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 4-(4-Oxobutyl)benzoic Acid Methyl Ester is used as a reagent in the preparation of Pemetrexed (P219500) and furoxanoxyalkyl esters of Pemetrexed as antifolates and nitric oxide donors for use as anticancer agents.<br>References Zhao, D., et al.: Zhongguo Yaowu Huaxue Zazhi, 18, 445 (2008); Yi, B., et al.: Zhongguo Yiyao Gongye Zazhi, 37, 798 (2006); Min, T., et al.: Med. Chem. Res., 18, 495 (2009)<br></p>Formula:C12H14O3Color and Shape:NeatMolecular weight:206.24N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:355.35400390625Doxofylline
CAS:Controlled Product<p>Applications Doxofylline is a xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as Theophylline and the evidence supporting the effects of Doxofylline in the treatment of lung diseases.<br>References Franzone, J., et al.: Drugs Exp. Clin. Res., 14, 479 (1988), Nicholson, C., et al.: Pulm. Pharmacol., 7, 1 (1994), Sullivan, P., et al.: Lancet, 343, 1006 (1994),<br></p>Formula:C11H14N4O4Color and Shape:NeatMolecular weight:266.25Ondansetron
CAS:Controlled Product<p>Applications Ondansetron is a specific serotonin (5-HT3) receptor antagonist. Antiemetic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kris, M.G., et al.: J. Clin. Oncol., 6, 659 (1988); Faris, P..L., et al.: Lances, 355, 792 (2000)<br></p>Formula:C18H19N3OColor and Shape:White To Light BeigeMolecular weight:293.363-((3-(N-Cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(3,5-difluorophenoxy)benzoic acid
CAS:Purity:98%Molecular weight:649.630004882813Ref: 10-F867169
5mgTo inquire10mgTo inquire25mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquireFebuxostat-d7
CAS:Controlled Product<p>Applications Febuxostat-d7, is the labeled analogue of Febuxostat-d7 (F229000), a Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout.<br>References Osada, Y., et al.: Eur. J. Pharmacol., 241, 183 (1993), Okamoto, K., et al.: J. Biol. Chem., 278, 1848 (2003), Mayer, M.D., et al.: Am. J. Therap., 12, 22 (2005), Tomlinson, B., et al.: Curr. Opin. Invest. Drugs, 6, 1168 (2005),<br></p>Formula:C16H9D7N2O3SColor and Shape:NeatMolecular weight:323.426-CHLORO-1-(4-METHOXYBENZYL)-3-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE
CAS:Purity:95.0%Molecular weight:280.70999145507814-(Benzylamino)-2-((3-chloro-4-hydroxyphenethyl)amino)pyrimidine-5-carboxamide
CAS:Purity:95.0%Molecular weight:397.8599853515625Chloromethyl Propyl Carbonate
CAS:Controlled Product<p>Applications Chloromethyl Propyl Carbonate (cas# 35273-90-6) is a compound useful in organic synthesis.<br></p>Formula:C5H9ClO3Color and Shape:Colourless OilyMolecular weight:152.58L-Phenylalanine-d8
CAS:Controlled Product<p>Applications Labelled analogue of L-Phenylalanine, an essential amino acid.<br>References Hollunger, G. et al.: Acta Pharmacol. Toxicol., 34, 391 (1974); Bagchi, S.P. et al.: Biochem. Pharmacol., 26, 900 (1977);<br></p>Formula:C9D8H3NO2Color and Shape:NeatMolecular weight:173.242-(Chloromethyl)-5-methylpyrimidine hydrochloride
CAS:Formula:C6H8Cl2N2Purity:98%Color and Shape:SolidMolecular weight:179.043,5,3',5'-Tetraiodo Thyrolactic Acid (~90%)
CAS:Controlled Product<p>Stability Hygroscopic, Temperature sensitive<br>Applications 3,5,3',5'-Tetraiodo Thyrolactic Acid is a thyroid hormone analogue. A Thyroxine (T425600) analogue.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Horst, C., et al.: Biochem. J., 261, 945 (1989); Kvetny, J., et al.: Horm. Metab. Res., 24, 322 (1992); Yamauchi, K., et al.: J. Biol. Chem., 274, 8460 (1999); Davis, P., et al.: J. Endocrinol. Invest., 25, 377 (2002);<br></p>Formula:C15H10I4O5Purity:~90%Color and Shape:BeigeMolecular weight:777.85Ethyl 2-(2-(dimethylamino)pyrimidin-4-yl)-1H-indole-5-carboxylate
CAS:Purity:95.0%Molecular weight:310.35699462890625ethyl 2-morpholin-4-yl-4-(trifluoromethyl)pyrimidine-5-carboxylate
Molecular weight:305.25698852539061-Methyl-nicotinamide Iodide
CAS:Controlled Product<p>Applications A nicotinic acid derivative which shows a dopaminergic neurotoxicity.<br>References Rollema, H., et al.: J. Med. Chem., 33, 2221 (1990),<br></p>Formula:C7H9IN2OColor and Shape:NeatMolecular weight:264.06Methotrexate γ-Methyl Ester
CAS:Controlled Product<p>Impurity Methotrexate EP Impurity H<br>Applications Methotrexate γ-methyl ester is an impurity of Methotrexate (M260675), a folic acid antagonist. Used as a antineoplastic and antirheumatic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958), Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985),<br></p>Formula:C21H24N8O5Color and Shape:NeatMolecular weight:468.473-(2-Amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile
CAS:Purity:98.0%Molecular weight:426.48400878906254-(2H-1,3-benzodioxol-5-yl)-6-(3,4-dimethylphenyl)pyrimidin-2-amine
CAS:Purity:95.0%Molecular weight:319.3640136718751-Methyluric Acid
CAS:Controlled Product<p>Applications A metabolite of Theophylline.<br>References Chen, Y., et al.: Clin. Exper. Pharmacol. Physiol., 36, 828 (2009), Yu, C., et al.: J. Bacteriol., 191, 4624 (2009), Jetter, A., et al.: Eur. J. Clin. Pharmacol., 65, 411 (2009),<br></p>Formula:C6H6N4O3Color and Shape:Light Yellow To Light BrownMolecular weight:182.14Tenofovir Disoproxil Fumarate
CAS:<p>Applications Acyclic phosphonate nucleotide analogue; reverse transcriptase inhibitor. Used as an anti-HIV agent. Antiviral.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>Formula:C19H30N5O10P·C4H4O4Color and Shape:White To Off-WhiteMolecular weight:635.51Regadenoson
CAS:Controlled Product<p>Applications Regadenoson is a selective and potent A2A adenosine receptor agonist (1). The adenosine A2A receptor is a G-protein-coupled receptor and a key therapeutic target for oncologic, inflammatory, Parkinson's and cardiovascular diseases (2). In rodent studies, it has been shown that co-administration of Regadenoson with Temozolomide (T017775) can increase Temozolomide concentration in the brain (3).<br>References (1) Gao, Z., et al.: J Pharmacol Exp Ther. 298, 209 (2001) (2) Yuan, G., et al.: Expert Opin Drug Discov. 10, 63 (2015) (3) Jackson, S., et al.: J Neurooncol. 126, 433 (2016)<br></p>Formula:C15H18N8O5Color and Shape:Off WhiteMolecular weight:390.355-Acetylamino-6-amino-3-methyluracil Hydrate
CAS:Controlled Product<p>Applications Metabolite of Caffeine (C080100).<br>References Wong, P., et al.: J. Pharm. Biomed. Anal., 28, 693 (2002), Nyeki, A., et al.: Brit. J. Clin. Pharmacol., 55, 62 (2003), Jetter, A., et al.: Eur. J. Clin. Pharmacol., 65, 411 (2009),<br></p>Formula:C7H12N4O4Color and Shape:NeatMolecular weight:216.19Thyroxine-13C6 4'-O-β-D-Glucuronide Disodium Salt
CAS:Controlled ProductFormula:C1513C6H17I4NNa2O10Color and Shape:NeatMolecular weight:1002.91Iopamidol
CAS:<p>Applications Nonionic radiocontrast medium. Diagnostic aid (radiopaque medium).<br>References Drayer, B., et al.: Am. J. Neuroradiol., 3, 59 (1982), Molyneux, A.J., et al.: Br. J. Radiol., 55, 117 (1982), Sovak, M., et al.: Radiology, 142, 115 (1982), Felder, E., et al.: Anal. Profiles Drug Subs., 17, 115 (1988),<br></p>Formula:C17H22I3N3O8Color and Shape:WhiteMolecular weight:777.09Theophylline-13C2d6
CAS:Controlled Product<p>Applications Labelled Theophylline is a xanthine derivative with diuretic, cardiac stimulant and smooth muscle relaxant activities; isomeric with theobromine. Small amounts occur in tea. Bronchodilator.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cohen, J.L., et al.: Anal. Profiles Drug Subs., 4, 466 (1975), Svedmyr, K., et al.: Allergy, 37, 111 (1982),<br></p>Formula:C513C2H2D6N4O2Color and Shape:NeatMolecular weight:188.193-(2-Chloropyrimidin-4-yl)-1-cyclopropyl-1H-indole
CAS:Purity:97.0%Molecular weight:269.7300109863281Methotrexate-d3 Hexaglutamate Trifluoroacetic Acid Salt
CAS:Controlled Product<p>Applications Methotrexate-d3 Hexaglutamate is the isotope labelled analog of Methotrexate Hexaglutamate (M260745); a metabolite of Methotrexate (M260675) which is a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C45H54D3N13O20•x(C2HF3O2)Color and Shape:NeatMolecular weight:1103.03114024-(3-Chlorothiophen-2-yl)-6-methylpyrimidin-2-amine
CAS:Purity:95+%Molecular weight:225.690002441406257-BROMO-2-(3-(PYRIMIDIN-2-YL)PHENETHYL)ISOINDOLIN-1-ONE
CAS:Purity:95.0%Molecular weight:394.2720031738281Methyl 4-((6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)benzoate
CAS:Purity:97.0%Molecular weight:324.33999633789063-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one Hydrochloride
CAS:Controlled Product<p>Impurity Ondansetron EP Impurity A/ Ondansetron USP Related Compound A<br>Applications 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one (Ondansetron EP Impurity A) is an impurity of Ondansetron (O655000), an antiemetic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Mackinnon, J.W.M., et al.: Eur. J. Cancer Clin. Oncol., 25, 61 (1989);<br></p>Formula:C16H20N2O·ClHColor and Shape:NeatMolecular weight:292.80Methotrexate-d3 Tetraglutamate Trifluoroacetate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Methotrexate-d3 Tetraglutamate is the isotope labelled analog of Methotrexate Tetraglutamate (M260730); a metabolite of Methotrexate (M260675) which is a folic acid antagonist, antineoplastic, and antirheumatic.<br>References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958); Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985)<br></p>Formula:C35H40D3N11O14•(C2HF3O2)xColor and Shape:NeatMolecular weight:844.8Succinimide
CAS:<p>Applications Succinimide is a reagent that is used in the synthesis of Lumiflavin (L473900), which is a toxic photolysis product of vitamin B2 (R415000).<br>References Zhao, X. et al.: Chemosphere, 63, 1116 (2006); Litke, S.V. et al.: Khim. Fiz., 10, 48 (1991); Ye, W. et al.: Guang. Yaox. Xueb., 12, 175 (1996);<br></p>Formula:C4H5NO2Color and Shape:White To Off-WhiteMolecular weight:99.094-[(4,6-Dimethylpyrimidin-2-yl)thio]aniline
CAS:Formula:C12H13N3SPurity:95.0%Color and Shape:SolidMolecular weight:231.32(R)-4-(TERT-BUTYL)-N-(6-(2,3-DIHYDROXYPROPOXY)-5-(2-METHOXYPHENOXY)-2-(4-METHOXYPHENYL)PYRIMIDIN-4-YL)BENZENESULFONAMIDE
CAS:Purity:95%Molecular weight:609.6900024414062Ethyl Tosylate
CAS:<p>Applications Ethyl Tosylate (cas# 80-40-0) is a compound useful in organic synthesis.<br></p>Formula:C9H12O3SColor and Shape:NeatMolecular weight:200.267-Methyl Xanthine
CAS:Controlled Product<p>Applications Metabolite of Theophylline and Caffeine.<br>References Yu, Ch. et al.: J. Bacteriol. 191, 4624 (2009); Geraets, L. et al.: Biochem. Pharmacol. 72, 902 (2006).<br></p>Formula:C6H6N4O2Color and Shape:NeatMolecular weight:166.141,3-Dimethyladamantane
CAS:<p>Impurity Memantine Related Compound A (1,3-Dimethyladamantane)<br>Applications 1,3-Dimethyladamantane is a dimethylated adamantane derivative. Memantine impurity A. Memantine Related Compound A (1,3-Dimethyladamantane).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formula:C12H20Color and Shape:NeatMolecular weight:164.29Phenylhydrazine
CAS:Controlled Product<p>Applications An aryl hydrazine used in the preparation of various dyes and pharmaceutical compounds. It is used in the investigation of oligosaccharides as well as the structure of photosystem II.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lattova, E. et al.: Meth. Mol. Biol., 534, 65 (2009); Anderson, L.B. et al.: J. Biol. Chem., 275, 4920 (2000);<br></p>Formula:C6H8N2Color and Shape:Yellowish LiquidMolecular weight:108.144-(furan-2-yl)-6-(5-methylthiophen-2-yl)pyrimidin-2-amine
CAS:Purity:95.0%Molecular weight:257.30999755859375Paraxanthine-1-methyl-d3
CAS:Controlled Product<p>Applications An adenosine receptor ligand and a major metabolite of caffeine.<br>References Proc. Natl. Acad. Sci. USA 78, 3260 (1981); Cell Mol. Neurobiol., 3, 69 (1983); Eur. J. Pharmacol., 179, 295 (1990)<br></p>Formula:C72H3H5N4O2Color and Shape:YellowMolecular weight:183.182-[5-amino-3-(2-thienyl)-1H-pyrazol-1-yl]-5-ethyl-6-methylpyrimidin-4(3H)-one
CAS:Purity:95.0%Molecular weight:301.3699951171875Pemetrexed Sodium Methyl Ester
Controlled Product<p>Applications Pemetrexed Sodium Methyl Ester is an impurity of Pemetrexed(P219550). Pemetrexed Disodium Heptahydrate is an chemotherapy drug for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed Disodium Heptahydrate exhibit inhibitory activities towards thymidylate synthase as well as other folate dependent enzymes.<br>References Vogelzang, N.J., et al.: J. Clin. Oncol., 21,2636 (2003); Paz-Ares, L., et al.: Lancet. Oncol., 13, 247 (2012);<br></p>Formula:C21H22N5NaO6Color and Shape:NeatMolecular weight:463.4191-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL METHANESULFONATE
CAS:Purity:90.0%Molecular weight:285.3599853515625N2-ISOBUTYRYL-2'-O-METHYL-GUANOSINE
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:367.361999511718753-Methyl-1H-purine-2,6(3H,7H)-dione
CAS:Formula:C6H6N4O2Purity:95%Color and Shape:Solid, Light yellow powderMolecular weight:166.14Sumatriptan-d6
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A serotonin 5HT1-receptor agonist. Antimigraine.<br>References Humphrey, P.P.A., et al.: Br. J. Pharmacol., 94, 1123 (1988),<br></p>Formula:C14H15D6N3O2SColor and Shape:NeatMolecular weight:301.44Caffeine-d3 (1-methyl-d3)
CAS:Controlled Product<p>Applications Caffeine-d3 (1-methyl-d3) (CAS# 26351-03-1) is a useful isotopically labeled research compound.<br></p>Formula:C8H7D3N4O2Color and Shape:NeatMolecular weight:197.204,6-Dichloro-2,5-diphenylpyrimidine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:301.17001342773442-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:298.34600830078125N-Methylguanidine Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications N-Methylguanidine is an alkylated guanidine which shows inhibitory action against trypsin catalysis. N-Methylguanidine inhibited metabolism of certain hepatic drugs that was mediated by cytochrome P 450 protein in human liver microsome and hepatocyte.<br>References Inagami, T. et al.: Biochemistry, 7, 4045 (1968); Hanada, K. et al.: Nephron, 103, 179 (2006);<br></p>Formula:C2H8ClN3Color and Shape:NeatMolecular weight:109.56(S)-4-(4-Aminobenzyl)-2-(1H)-oxazolidinone
CAS:Controlled Product<p>Impurity Zolmitriptan USP Related Compound G<br>Applications An intermediate of Zolmitriptan, as a novel inhibitor of the cytochrome P-450 enzyme aromatase. Zolmitriptan USP Related Compound G.<br>References Ahmed, S., et al.: Bioorg. Med. Chem. Lett., 5, 2789(1995), Ahmed, S., et al.: Drug. Des. Discov., 15, 239 (1998), Brodie, A., et al.: Steroids, 65, 171 (2000),<br></p>Formula:C10H12N2O2Color and Shape:NeatMolecular weight:192.21LY-338979
CAS:<p>Applications LY 338979 is a metabolite of the antifolate Pemetrexed (P219500).<br>References Woodland, J.M. et al.: Drug Metab. Dispos., 25, 693 (1997);<br></p>Formula:C20H21N5O7Color and Shape:NeatMolecular weight:443.41Ethyl 3-aminopyrazole-4-carboxylate
CAS:<p>Ethyl 3-aminopyrazole-4-carboxylate is an anticancer drug that inhibits the growth of cancer cells by inhibiting protein synthesis. It has been shown to inhibit the activity of dpp-iv and pde5, which are enzymes involved in cellular proliferation. Ethyl 3-aminopyrazole-4-carboxylate has also been shown to have antiinflammatory properties, which may be due to inhibition of prostaglandin synthesis. <br>Ethyl 3-aminopyrazole-4-carboxylate is a multinuclear compound that reacts with nitrogen atoms from the pyrazoles to form a stable molecule. Dimethylformamide is used as a solvent for this reaction. The synthesis of ethyl 3-aminopyrazole-4-carboxylate starts with acetylation, which converts the carboxylic acid group into an acetic acid group. The acetic acid group reacts with ammonia and hydrogen cyan</p>Formula:C6H9N3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:155.16 g/molMemantine impurity IV
CAS:<p>Memantine impurity IV is a hydrolysis product of memantine. It appears as a white to off-white powder and has a molecular weight of 198.1 g/mol. Memantine impurity IV is an intermediate in the production of memantine and is therefore not used for any other purpose. The compound contains hydroxy groups, hydroxy, alcohols, and bridgehead groups which are efficient at hydrolyzing to form amino acids.</p>Formula:C12H21NO·HClPurity:Min. 95%Color and Shape:White PowderMolecular weight:231.76 g/molTenofovir disoproxil related compound B
CAS:<p>Tenofovir disoproxil related compound B is a peptidyl prodrug that is metabolized by esterases to tenofovir. It has been shown to be an effective agent against Mycobacterium tuberculosis and other bacterial species. Tenofovir disoproxil related compound B was also found to inhibit protein synthesis in Mycobacterium avium and Mycobacterium smegmatis, but not in Escherichia coli. This drug binds to the ribosome's 30S subunit, which blocks the binding of aminoacyl-tRNA and prevents the formation of peptide bonds. The mechanism of action for this drug is similar to that of the antibiotic erythromycin.</p>Formula:C8H9N5Purity:Min. 98 Area-%Molecular weight:175.19 g/molN-Acetylmemantine
CAS:<p>N-Acetylmemantine is a drug that inhibits the activity of acetylcholinesterase in the brain. It has been shown to inhibit cancer cell growth and induce apoptosis, as well as inhibit the reaction of hydrolysis of acetonitrile with hydrochloric acid in an organic solvent. N-Acetylmemantine is synthesized by heating ethylene in the presence of hydrochloric acid. The synthesis yields a white solid that consists mainly of N-acetylmethamphetamine. This drug interacts with cellular membranes, which may be due to its ability to react with cholesterol or phospholipids. The interaction leads to changes in membrane permeability, which can result in apoptosis.</p>Formula:C14H23NOPurity:Min. 95%Color and Shape:White PowderMolecular weight:221.34 g/molPemetrexed related impurity 2
<p>Pemetrexed related impurity 2 is a drug product that is an analytical impurity found in the metabolite of pemetrexed. It has been shown to be naturally occurring and is not toxic at high doses. This impurity has been synthesized as an impurity standard for HPLC. Pemetrexed related impurity 2 is used in research and development studies for drug development, such as pharmacopoeia testing for high purity standards.</p>Formula:C20H21N5O8Purity:Min. 95%Molecular weight:459.41 g/mol4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid
CAS:<p>4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid is a drug with low bioavailability. It is used to treat leishmaniasis, an infection caused by the parasite Leishmania. 4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoic acid inhibits the synthesis of folic acid by blocking the enzyme dihydrofolate reductase in the bacteria. This drug also has been shown to be effective against autoimmune diseases and inflammatory bowel disease. The terminal half-life of 4-[(2,4-diamino6 pteridinyl)methyl]methylamino benzoic acid is approximately 5 hours and it can be detected in urine for up to 12 hours after administration.</p>Formula:C15H15N7O2Purity:(1H-Nmr) Min. 95 Area-%Color and Shape:Brown Yellow PowderMolecular weight:325.33 g/mol4-[2'-(7''-Deazaguanine)ethyl]benzoic acid N-hydroxysuccinimide ester
CAS:<p>4-[2'-(7''-Deazaguanine)ethyl]benzoic acid N-hydroxysuccinimide ester is a useful intermediate in the synthesis of 7''-deazaguanine, which is a key building block in the synthesis of DNA. 4-[2'-(7''-Deazaguanine)ethyl]benzoic acid N-hydroxysuccinimide ester is a versatile building block that can be used in the synthesis of complex compounds. It has been shown to react with amines, sulfonyl chlorides, and epoxides to form amides, sulfonamides, and epoxy amines respectively. The CAS number for this compound is 204257-65-8.</p>Formula:C19H17N5O5Purity:Min. 95%Molecular weight:395.37 g/mol


